Engineering of an Inhalable DDA/TDB Liposomal Adjuvant: A Quality-by-Design Approach Towards Optimization of the Spray Drying Process
- 22 June 2013
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 30 (11) , 2772-2784
Abstract
Purpose The purpose of this study was to identify and optimize spray drying parameters of importance for the design of an inhalable powder formulation of a cationic liposomal adjuvant composed of dimethyldioctadecylammonium (DDA) bromide and trehalose-6,6′-dibehenate (TDB). Methods A quality by design (QbD) approach was applied to identify and link critical process parameters (CPPs) of the spray drying process to critical quality attributes (CQAs) using risk assessment and design of experiments (DoE), followed by identification of an optimal operating space (OOS). A central composite face-centered design was carried out followed by multiple linear regression analysis. Results Four CQAs were identified; the mass median aerodynamic diameter (MMAD), the liposome stability (size) during processing, the moisture content and the yield. Five CPPs (drying airflow, feed flow rate, feedstock concentration, atomizing airflow and outlet temperature) were identified and tested in a systematic way. The MMAD and the yield were successfully modeled. For the liposome size stability, the ratio between the size after and before spray drying was modeled successfully. The model for the residual moisture content was poor, although, the moisture content was below 3% in the entire design space. Finally, the OOS was drafted from the constructed models for the spray drying of trehalose stabilized DDA/TDB liposomes. Conclusions The QbD approach for the spray drying process should include a careful consideration of the quality target product profile. This approach implementing risk assessment and DoE was successfully applied to optimize the spray drying of an inhalable DDA/TDB liposomal adjuvant designed for pulmonary vaccination. Diagram of an optimal operating space highlighting the process design space where the critical criteria are met: White: No criteria met. Dark blue: One criterion met. Light blue: Two criteria met. Green: All criteria met.Keywords
This publication has 35 references indexed in Scilit:
- Design of Experiments-Based Monitoring of Critical Quality Attributes for the Spray-Drying Process of Insulin by NIR SpectroscopyAAPS PharmSciTech, 2012
- New developments in dry powder pulmonary vaccine deliveryTrends in Biotechnology, 2011
- Stabilization of liposomes during dryingExpert Opinion on Drug Delivery, 2011
- Quality by design – Spray drying of insulin intended for inhalationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Quality by Design: An Overview of the Basic Concepts2008
- Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological RequirementsPLOS ONE, 2008
- Process Analytical Technology: Application to Particle Sizing in Spray DryingAAPS PharmSciTech, 2008
- Pharmaceutical Particle Engineering via Spray DryingPharmaceutical Research, 2007
- Innate Immunity in the LungsProceedings of the American Thoracic Society, 2005
- Spray drying of food ingredients and applications of CFD in spray dryingChemical Engineering and Processing - Process Intensification, 2001